International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. - Test2 - elhamkhani - TriplyDB

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.

http://www.wikidata.org/entity/Q34116505

about

Genetic susceptibility testing for beryllium: worker knowledge, beliefs, and attitudes Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers Contralateral prophylactic mastectomy: current perspectives Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease Prevention Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers RANKL/RANK: from bone loss to the prevention of breast cancer Understanding the needs of women considering risk-reducing salpingo-oophorectomy.Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy.Two decades after BRCA: setting paradigms in personalized cancer care and prevention Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?Personalized medicine: a personal view Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers New strategies in ovarian cancer: uptake and experience of women at high risk of ovarian cancer who are considering risk-reducing salpingo-oophorectomy.How can we best respect patient autonomy in breast cancer treatment decisions?Psychometric testing of the decisional conflict scale: genetic testing hereditary breast and ovarian cancer.Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers Clinical Considerations of BRCA1- and BRCA2-Mutation Carriers: A Review.Metformin- A Promising Agent for Chemoprevention in BRCA1 Carriers.Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance Online tool to guide decisions for BRCA1/2 mutation carriers.Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice.Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older women.Post-mortem testing; germline BRCA1/2 variant detection using archival FFPE non-tumor tissue. A new paradigm in genetic counseling.Public perception of risk-reducing salpingectomy for preventing ovarian cancer Recognizing BRCA gene mutation risk subsequent to breast cancer diagnosis in southwestern Ontario PARP Inhibitors for the Treatment and Prevention of Breast Cancer.Choices for young women at intermediate risk of breast cancer International rates of breast reconstruction after prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers Open biomedical pluralism: formalising knowledge about breast cancer phenotypes.Role of Breast Surgery in BRCA Mutation Carriers.Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers.Management of breast cancer--part I.Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.A cost analysis of a cancer genetic service model in the UK Impact of genetic risk assessment on nutrition-related lifestyle behaviours

P2860

Q23916053-69B879A5-2E56-4F69-B2D8-B3A93CFE700F Q24654487-17195FC1-5B0F-4C7C-8CB0-B1064031F435 Q26744320-169FF236-5291-43EB-BC25-1644A7016328 Q26744525-5A261F89-196D-49D9-A745-E352BEF25486 Q26773464-29C84CC8-C064-4846-B4B4-051E997D53D9 Q27003935-B2AFC5A7-B234-4630-8499-6F10E633A7A4 Q28075004-D29D5497-E64D-4F67-98D7-62867A7D7D8B Q30419497-EA635E0B-486E-4A5A-A90B-3926A8F7FF74 Q33564013-0D35888A-BE24-4E8B-BA04-01A58529A66B Q33633402-F566E4F5-F2DA-42CB-AD83-28C02A778DFA Q33650424-BD34B8F5-E6F8-4A91-87C8-5105D178D6BC Q33820594-94D80175-05F9-443C-AB5B-40FBE64580F7 Q34125241-575D0B11-F450-4E19-A944-DD6F0F7EDDAA Q34171954-CD436973-4B5A-4605-BEC2-2B6FD9CAC18F Q34309892-10E4E145-F88A-4946-BE87-B372B48D647F Q34475484-9A4B375B-2C97-4EAC-AB35-995C77B2AA26 Q35021170-13FAF4EF-13A5-4D61-AC19-1B8C52FF8A3E Q35127923-D2EE3219-0ABC-4EBA-9C44-36AD03A9DDC7 Q35572187-3A3718A1-DD59-452F-93FF-54747B94FB14 Q35684391-F0903B7B-3D86-4978-9DCD-240B2A6BC9C4 Q35687632-79F24CD9-73E5-4B4A-8687-336E44ED01E9 Q35761000-875D5CEF-DA3C-4F9C-8660-69DBE504D9E7 Q35777905-EDC4059E-404B-4E84-A63D-3C97FF625F1F Q35808372-555FA312-2B68-4888-8AC3-12D68C7604E5 Q35815469-4ECF3F93-1291-4F57-BE06-97287C2A5533 Q35879809-B484E8C5-B017-4AE9-9527-1C2E54C5D753 Q35886203-A4DA1480-4C20-405A-A23E-B6DD44FDEC5B Q35890339-B1D9DD0B-B5D5-4461-ABFD-0E29B9078A4F Q35962026-6230DB60-4DEB-4A21-81E9-38EDC4F8CAFA Q35993616-3DD73728-7BC9-4D99-8A67-DA252B41B483 Q36000212-78079806-3F78-4870-A377-0EEF030EA52C Q36168564-4AB888D7-3D1B-400E-8FAD-ADC3EC9792BA Q36251806-6BCDC04C-365F-4373-9726-CE3395A8E81C Q36457900-B32FF993-8DCD-4B3A-9518-DD26B4FE4378 Q36738628-6A2D6E38-817D-45A6-8099-43F6517F1EF7 Q36755872-7029F889-BB41-4B3F-ABC0-05817995AA37 Q36916140-E324D6EC-F7B3-40BA-9440-16C2F2E6C96E Q37122297-09373A7D-3179-4EF0-887A-3622AB1A140C Q37124110-EDC27AC1-BB9D-438E-9B62-DEB08C2476E7 Q37130341-D0446238-B259-4217-B52E-97650DD09FE0

P2860

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.

http://www.wikidata.org/entity/Q34116505

description

2008 nî lūn-bûn

@nan

2008 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

International variation in rat ...... 1 and BRCA2 mutation carriers.

@ast

International variation in rat ...... 1 and BRCA2 mutation carriers.

@en

International variation in rat ...... 1 and BRCA2 mutation carriers.

@nl

type

label

International variation in rat ...... 1 and BRCA2 mutation carriers.

@ast

International variation in rat ...... 1 and BRCA2 mutation carriers.

@en

International variation in rat ...... 1 and BRCA2 mutation carriers.

@nl

prefLabel

International variation in rat ...... 1 and BRCA2 mutation carriers.

@ast

International variation in rat ...... 1 and BRCA2 mutation carriers.

@en

International variation in rat ...... 1 and BRCA2 mutation carriers.

@nl

P1433

Q34116505-B96FD241-83C0-4DE2-986A-3C9DEDAED012

P1476

Q34116505-6069EA8D-CBD2-4B30-963B-0A5FD72D3AC6

P2093

Q34116505-27BE681A-8C04-4F66-8349-0C5D67B29ECB

Q34116505-3434F303-EA00-4037-A7EA-BB5D053D4F1C

Q34116505-3DC3F69B-8AF7-446D-9C64-5E9F8729EA07

Q34116505-3E289339-86D1-42BC-ADDF-FB9A7F69EF12

Q34116505-46A97707-AC14-441E-A4CD-531B1135793A

Q34116505-7065F9BE-B455-48C8-9522-20DEE2D40B68

Q34116505-7A29F86F-FEEF-4B8B-8F36-62254F63DCA3

Q34116505-86C0464B-BD16-4297-87AB-ECF070E3B080

Q34116505-9097C66F-AA1C-484C-AFCD-07FBF3414991

Q34116505-92ED1CD2-6824-4C2A-87A7-A617608CA908

P2860

Q34116505-0D60517B-4F75-4F27-87D1-DB116389D6F3

Q34116505-1799B971-4545-4F34-9F5D-0D63994A0360

Q34116505-2017037F-51AD-4F62-A1E7-C55EB2A4CB1E

Q34116505-44E3888D-AF70-436C-A6BD-D8AA2F489761

Q34116505-48EEFE66-4CC6-4BC4-8AA6-A24BD2EBFB88

Q34116505-4BDDE17E-C71C-430D-B6A4-8C5667EACB47

Q34116505-539B7038-09CA-4DE4-8BC5-502BC33E1853

Q34116505-5A886EDB-6950-4F10-BB37-2B167E5D1814

Q34116505-607CED75-1BFC-4ECF-9290-1266C4FE9D68

Q34116505-63FF200F-7182-401B-ACD0-8798A79A1166

P304

Q34116505-775BC2F2-F566-4996-8A65-153EA9F706CA

P31

Q34116505-8AEDB4F6-4E06-48F9-8648-7AB075947BFF

P356

Q34116505-133D0EDE-503E-4E72-ADE0-392C151F82A0

P433

Q34116505-C9123A3B-AC79-40DE-AC72-735732DF0912

P478

Q34116505-A98B8E8C-DC1C-4509-91A6-DE52B3652D50

P50

Q34116505-5097F90C-7F77-4227-998B-5618F5B74CEB

Q34116505-7B455919-69AE-4410-86A7-6B17E961E7E9

Q34116505-7C79342B-E6BF-441E-A662-BC680F41096E

Q34116505-A62140AC-58A8-49E3-9354-867FF6949A93

Q34116505-ADAA0573-A8D1-4C3F-A198-883189572CE4

Q34116505-C4FB430C-2541-4185-8227-3FE98293356A

Q34116505-FE4F6FF1-FF67-4EC7-B9F5-338449F0D89F

P577

Q34116505-405E6C20-1C66-49B3-80E6-DEB085C23E04

P5875

Q34116505-7034A9C5-C328-40CD-A9CA-726550E1F680

P698

Q34116505-1F35E5B2-A9D2-45D5-A302-F4347C75FA3B

P932

Q34116505-AC675192-662C-44CC-A417-6292BCEE2CD7

P356

P1433

International Journal of Cancer

P1476

International variation in rat ...... 1 and BRCA2 mutation carriers.

@en

P2093

Barry Rosen

http://www.w3.org/2001/XMLSchema#string

Charmaine Kim-Sing

http://www.w3.org/2001/XMLSchema#string

Eitan Friedman

http://www.w3.org/2001/XMLSchema#string

Henry Lynch

http://www.w3.org/2001/XMLSchema#string

Hereditary Breast Cancer Clinical Study Group

http://www.w3.org/2001/XMLSchema#string

Jacek Gronwald

http://www.w3.org/2001/XMLSchema#string

Jan Klijn

http://www.w3.org/2001/XMLSchema#string

Kelly A Metcalfe

http://www.w3.org/2001/XMLSchema#string

Nadine Tung

http://www.w3.org/2001/XMLSchema#string

Pal Moller

http://www.w3.org/2001/XMLSchema#string

P2860

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.

Variation in rates of uptake of preventive options by Canadian women carrying the BRCA1 or BRCA2 genetic mutation.

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.

An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling

P304

2017-2022

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.23340

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P50

William D Foulkes

Steven A. Narod

Siranoush Manoukian

Daphna Birenbaum-Carmeli

Susan M Domchek

Fergus J. Couch

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5654105

http://www.w3.org/2001/XMLSchema#string

P698

18196574

http://www.w3.org/2001/XMLSchema#string

P932

2936778

http://www.w3.org/2001/XMLSchema#string